ID: ALA2011700

Max Phase: Preclinical

Molecular Formula: C32H23F3N2O4S

Molecular Weight: 588.61

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(O)c1ccc(CN2C(=O)/C(=C/c3cccc(OCc4ccccc4)c3)S/C2=N\c2ccc(C(F)(F)F)cc2)cc1

Standard InChI:  InChI=1S/C32H23F3N2O4S/c33-32(34,35)25-13-15-26(16-14-25)36-31-37(19-21-9-11-24(12-10-21)30(39)40)29(38)28(42-31)18-23-7-4-8-27(17-23)41-20-22-5-2-1-3-6-22/h1-18H,19-20H2,(H,39,40)/b28-18-,36-31-

Standard InChI Key:  HLJVHKMEFSMMFG-SJIIYNIPSA-N

Associated Targets(Human)

T-cell protein-tyrosine phosphatase 1317 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Low molecular weight phosphotyrosine protein phosphatase 1161 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Protein-tyrosine phosphatase 1B 8528 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

C2C12 756 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Protein-tyrosine phosphatase 1B 163 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 588.61Molecular Weight (Monoisotopic): 588.1331AlogP: 7.79#Rotatable Bonds: 8
Polar Surface Area: 79.20Molecular Species: ACIDHBA: 5HBD: 1
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 4.10CX Basic pKa: 2.92CX LogP: 7.66CX LogD: 4.84
Aromatic Rings: 4Heavy Atoms: 42QED Weighted: 0.21Np Likeness Score: -1.34

References

1. Ottanà R, Maccari R, Amuso S, Wolber G, Schuster D, Herdlinger S, Manao G, Camici G, Paoli P..  (2012)  New 4-[(5-arylidene-2-arylimino-4-oxo-3-thiazolidinyl)methyl]benzoic acids active as protein tyrosine phosphatase inhibitors endowed with insulinomimetic effect on mouse C2C12 skeletal muscle cells.,  50  [PMID:22381357] [10.1016/j.ejmech.2012.02.012]

Source